http://www.pharmaceutical-technology.com/news/ec-approves-sanofi-dupixent/
0
0
12/16/22 at 7:04am
Organization
Pharmaceutical Technology
Author
Vishnu Priyan
31 words
0
Comments
The EC has granted expanded marketing authorisation for Sanofi’s Dupixent (dupilumab) for the treatment of prurigo nodularis in adults.
You are the first to view
Create an account
or login to join the discussion